En español
NIDA

Treatment Research

Interim Methadone Raises Odds of Enrolling in Comprehensive Treatment

Reports on a study to investigate the use of methadone maintenance for heroin addicts wait-listed for a treatment program to encourage their likelihood to enroll in the program.

Genes and Smoking

NIDA Director Nora Volkow

Reports on the research underway to identify gene variations associated with nicotine addiction and the interaction of genetic makeup, experiences, and surroundings to addiction.

Depot Naltrexone Appears Safe and Effective for Heroin Addiction

Presents results of a pilot study to investigate the safety and efficacy of a new long-lasting injectable formulation of naltrexone to treat of heroin addiction in an outpatient setting.

Meeting Reviews Progress On Prescription Opioid Misuse

Describes a meeting of researchers and clinicians who gathered to discuss the challenges in balancing appropriate pain treatment with efforts to minimize prescription opioid misuse.

Journal Highlights Global Nexus of Drug Abuse and HIV/AIDS

Reviews a journal supplement that compiles studies on drug-related HIV transmission, with a focus on injection drug use, in 16 different localities across the globe.

NIDA's Newest Division Mines Clinical Applications From Basic Research

Describes the role of the Division of Clinical Neuroscience and Behavioral Research in NIDA’s drug abuse and addiction research plan.

Gene Experiment Confirms a Suspected Cocaine Action

Reports on the work of addiction researchers who are learning how acute and chronic cocaine exposure regulates certain genes, based on knowledge from developmental and cancer biology.

Endorphin Derivative Inhibits Reward From Morphine and Nicotine in Rats

Describes research investigating a naturally occurring brain chemical that shows early promise as a treatment for addiction in animal studies.

Sertraline Does Not Help Methamphetamine Abusers Quit

Describes a new research finding indicating that the antidepressant sertraline (Zoloft), prescribed to relieve depression during the methamphetamine withdrawal process, may make quitting harder.

Pages

Subscribe to Treatment Research